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Stem cells are capable of renewing themselves through cell division and have the
remarkable ability to differentiate into many different types of cells. They therefore
have the potential to become a central tool in regenerative medicine. During the last
decade, advances in tissue engineering and stem cell-based tooth regeneration have
provided realistic and attractive means of replacing lost or damaged teeth. Investigation
of embryonic and adult (tissue) stem cells as potential cell sources for tooth regeneration
has led to many promising results. However, technical and ethical issues have hindered the
availability of these cells for clinical application. The recent discovery of induced pluripotent
stem (iPS) cells has provided the possibility to revolutionize the field of regenerative
medicine (dentistry) by offering the option of autologous transplantation. In this article,
we review the current progress in the field of stem cell-based tooth regeneration and
discuss the possibility of using iPS cells for this purpose.
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INTRODUCTION
Teeth consist of multiple hard tissues, including enamel, dentin,
and cementum, and have an integrated attachment complex
with alveolar bone through the periodontal ligament. After
completion of tooth formation, the only vascularized tis-
sue containing nerves is the dental pulp, which is encased
in mineralized dentin. Because teeth have multiple func-
tions, including feeding, articulation, and esthetics, their loss
can cause not only physical but also psychological suffering
that compromises an individual’s self-esteem and quality of
life (Pihlstrom et al., 2005; Polzer et al., 2010; Jung et al.,
2011).
With aging, the number of people who lose their teeth
increases. Furthermore, the number of people who have more
than five congenitally missing adult teeth has increased (Mayama
et al., 2001). Thus, tooth loss is a major challenge in contem-
porary dentistry and accounts for a large part of daily dental
practice. Currently, missing teeth are restored using dentures
or dental implants prepared from synthetic materials. Although
these prostheses serve the purpose, denture therapy is associ-
ated with complications such as denture-induced stomatitis and
traumatic ulcers (Holm-Pedersen et al., 2008). The use of dental
implants may also lead to surgery failure because of many fac-
tors that interfere with osseointegration (Esposito et al., 1998). To
overcome these shortcomings, the novel approach of stem cell-
based tooth regeneration has been suggested as an alternative,
considering the advances in tissue engineering and stem cell
biology.
Recent progress in tissue engineering techniques and stem cell
research has provided important insights for improving tooth
regeneration. The main concept in current tooth regeneration is
to mimic the natural tooth development process either in vitro or
in vivo using stem cells. Because tooth development is character-
ized by a sequential reciprocal epithelial–mesenchymal interac-
tion between oral epithelial and neural crest (NC)-derived dental
ectomesenchymal cells (Thesleff and Sharpe, 1997), numerous
studies have attempted to find an optimal source of stem cells
that have the potential to differentiate into these cells or their
progeny. In particular, the recent discovery of induced pluripotent
stem (iPS) cells, which have been genetically reprogrammed to
an embryonic stem cell (ESC)-like state, has had a major impact
in this field (Takahashi and Yamanaka, 2006). In this review, we
focus on the important previous findings in the study of tooth
regeneration using stem cells and discuss the potential of iPS cells
for tooth regeneration in light of recent results obtained by our
group.
CURRENT STEM CELL-BASED TOOTH REGENERATION
Stem cells are unspecialized cells defined as clonogenic cells that
have the capacity for self-renewal and the potential to differentiate
into one or more specialized cell types. (Weissman, 2000; Slack,
2008). Their microenvironment, composed of heterologous cell
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types, extracellular matrix, and soluble factors, enables them to
maintain their stemness (Watt and Hogan, 2000; Spradling et al.,
2001; Scadden, 2006). Because of their unique properties, stem
cells have the potential to be important in tissue engineering
strategies for the regeneration of diseased, damaged, and missing
tissues and even organs. In general, stem cells can be divided into
three main types: ESCs that are derived from embryos; adult stem
cells that are derived from adult tissue; and iPS cells that are gen-
erated artificially by reprogramming adult somatic cells so that
they behave like ESCs. In this section, we outline recent results
obtained using ESCs and adult stem cells for tooth regeneration.
ESCs
The isolation and expansion of murine ESCs in the 1980s ignited
interest in regenerative medicine research (Evans and Kaufman,
1981). ESCs are pluripotent stem cells derived from the undif-
ferentiated inner cell mass of the blastocyst (an early stage of
embryonic development) and they continue to grow indefinitely
in an undifferentiated diploid state when cultured in optimal con-
ditions in the presence of a feeder layer and leukemia inhibitory
factor (LIF). The study of ESCs has gained further interest
with the successful establishment of primate and human ESCs
(Thomson et al., 1995, 1998; Shamblott et al., 1998; Reubinoff et
al., 2000), which can differentiate into derivatives of all three pri-
mary germ layers: ectoderm, endoderm, and mesoderm (Evans
and Kaufman, 1981; Thomson et al., 1998). Because of the
pluripotency of ESCs, several attempts have been made to use
them to functionally regenerate cardiomyocytes, dopaminergic
neurons, and pancreatic islets in animal models, keeping in view
future clinical applications (Lumelsky et al., 2001; Kim et al.,
2002; Laflamme et al., 2007; Van Laake et al., 2008). In den-
tistry, ESCs have been used for oral and craniofacial regeneration,
including mucosa, alveolar bone, and periodontal tissue regener-
ation (Roh et al., 2008; Inanç et al., 2009; Ning et al., 2010; Shamis
et al., 2011). Ohazama et al. (2004) demonstrated that after
recombination with embryonic day (E)10 oral epithelium, ESCs
expressed the unique set of genes for odontogenic mesenchymal
cells, such as Lhx7, Msx1, and Pax9, suggesting that ESCs can
respond to inductive signals from embryonic dental epithelium.
Although these approaches have the potential to be useful for
tooth regeneration and for understanding basic tooth develop-
ment, it will be necessary to address several major issues before
they can be implemented in clinical practice, including possible
tumorigenesis (teratoma formation) when transplanted, ethical
issues regarding the use of embryos, and allogeneic immune
rejection.
ADULT STEM CELLS IN DENTAL TISSUES
Adult stem cells have been identified in many tissues and organs
and have been shown to undergo self-renewal, to differentiate
for the maintenance of normal tissue, and to repair injured tis-
sues. The first adult stem cells isolated from dental tissues were
dental pulp stem cells (DPSCs) (Gronthos et al., 2000). These
cells have a typical fibroblast shape and express markers similar
to those of mesenchymal stem cells (MSCs). When transplanted
with hydroxyapatite/tricalcium phosphate (HA/TCP) powder in
immunocompromised mice, they formed a dentin-like structure
lined with odontoblast-like cells that surrounded a pulp-like
interstitial tissue (Gronthos et al., 2000). DPSCs could differ-
entiate in vitro into other mesenchymal cell derivatives such
as odontoblasts (D’Aquino et al., 2008), adipocytes, chondro-
cytes, and osteoblasts (D’Aquino et al., 2007; Koyama et al.,
2009; Yu et al., 2010) and could also differentiate into function-
ally active neurons (Arthur et al., 2008, 2009). MSC-like cells
have also been isolated from the dental pulp of human decid-
uous teeth [stem cells from human exfoliated deciduous teeth
(SHEDs)] (Miura et al., 2003). They have the ability to differen-
tiate in vitro to neuron-like cells, odontoblasts, osteoblasts, and
adipocytes, show higher proliferation rates and increased num-
bers of population doublings compared with DPSCs, and can
form spherical aggregations. When these cells are transplanted
mixed with HA/TCP in vivo, they can form dentin and bone but
not dentin–pulp complexes. Comparison of the gene expression
profiles of DPSCs and SHEDs demonstrated that 4386 genes were
differentially expressed by two-fold or more (Nakamura et al.,
2009). In addition to genes that participate in pathways related to
cell proliferation and extracellular matrix formation, FGF, trans-
forming growth factor (TGF)-β, and collagen I and III showed a
higher level of gene expression in SHEDs than inDPSCs. Cordeiro
et al. (2008) suggested that SHEDs could be the ideal source of
stem cells for repairing damaged teeth or for induction of bone
formation.
Stem cells from the apical papilla (SCAPs) are found in the
papilla tissue in the apical part of the roots of developing teeth.
The third molars and teeth with open apices are an important
source of SCAPs. These cells have the potential to differentiate
into osteoblasts, odontoblasts, and adipocytes and show higher
rates of proliferation in vitro compared with DPSCs (Sonoyama
et al., 2006, 2008; Huang et al., 2008). Transplantation of SCAPs
and periodontal ligament stem cells (PDLSCs) into tooth sock-
ets of minipigs allowed the formation of dentin and periodon-
tal ligament (Sonoyama et al., 2006). Dental follicle stem cells
(DFSCs) have also been isolated from the follicles of developing
third molars (Morsczeck et al., 2005). They can differentiate into
osteoblasts, adipocytes, and nerve-like cells in vitro (Kémoun et
al., 2007; Coura et al., 2008; Yao et al., 2008) and form cementum
and periodontal ligament in vivo (Handa et al., 2002; Yokoi et al.,
2007).
Future therapeutic approaches for the restoration of damaged
dentin, pulp, cementum, and periodontal ligaments may make
use of autologous stem cells such as DPSCs, SHEDs, SCAPs, and
DFSCs that have been stored after removal from the patient.
Dental epithelial stem cells were identified in the continu-
ously growing rodent incisor (Harada et al., 1999). These cells
are maintained in the stem cell niche located at the apical end
of the incisor, named the “apical bud” region, and they con-
stantly produce enamel-secreting ameloblasts through interaction
with mesenchymal cells (Harada et al., 1999). FGF10, Notch,
and Sprouty have been suggested to play a role in the contin-
uous growth of rodent incisors and the maintenance of dental
epithelial stem cells (Harada et al., 1999; Tummers and Thesleff,
2003; Klein et al., 2006; Yokohama-Tamaki et al., 2006). Although
dental epithelial stem cells appear to be attractive for the regen-
eration of enamel-forming ameloblasts in rodents, this stem cell
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niche may be specific to rodent incisors; these cells differ from
all human teeth, in which dental epithelial stem cells and their
progeny are lost after eruption of the tooth.
The epithelial rests of Malassez (ERMs) are quiescent epithe-
lial remnants of Hertwig’s root sheath (HERS) that remain in
the adult tooth and play a role in cementum repair and regen-
eration (Rincon et al., 2006). A recent study demonstrated that
ERMs contain a unique population of stem cells that are capable
of undergoing epithelial–mesenchymal transition and differenti-
ate into diverse lineages indicative of mesodermal and ectodermal
origin, including bone, fat, and cartilage as well as neuron-like
cells (Xiong et al., 2013). In addition, ERMs can be induced to
form enamel-like tissues after transplantation into athymic rat
omentum with primary dental pulp cells (Shinmura et al., 2008),
suggesting that the stem cells in ERMs may be able to regenerate
enamel.
ADULT STEM CELLS IN NON-DENTAL TISSUES
Although most adult stem cells in non-dental tissues have gen-
erally been considered to be limited to specific cell fates, recent
studies have demonstrated that they have plasticity and can dif-
ferentiate into cell types derived from different germ layers. In
particular, bone marrow-derived adult stem cells have shown
considerable capacity to differentiate into diverse cell types such
as endothelium, neural tissue, liver, and heart (Asahara et al.,
1997; Lagasse et al., 2000; Mezey et al., 2000; Orlic et al., 2001).
Notably, MSCs derived from bone marrow can respond to induc-
tive stimulation from dental epithelium and contribute to tooth
regeneration (Ohazama et al., 2004). Recombination between
odontogenic-inducing epithelium and bonemarrow-derived cells
has been demonstrated to involve the expression of odonto-
genic genes such as Pax9, Msx1, and Lhx7 and the formation
of a tooth crown with organized enamel, dentin, and pulp sur-
rounded by bone after transplantation under the mouse kidney
capsule (Ohazama et al., 2004). Furthermore, c-kit-enriched bone
marrow-derived cells were shown to be able to differentiate into
ameloblast-like cells (Hu et al., 2006b).
The prospective stem cells described above have shown
remarkable capability for tooth regeneration. However, with
regard to clinical application, they share the common obstacles
of ethical concern arising from their embryonic origin, the risk
of tumorigenesis, and the possibility of immune rejection after
allogeneic transplantation. The development of iPS cells may
overcome many of these issues because of their properties, and
iPS cell-derived odontogenic cells can be expected to play signifi-
cant roles in future strategies for clinical translational research on
tooth regeneration.
iPS CELLS
Generating patient-specific pluripotent stem cells with properties
similar to those of ESCs has long been a central aim in research on
stem cell-based regenerative medicine. Through global changes
in the epigenetic and transcriptional environment, nuclear repro-
gramming reverses cell fate, converting differentiated cells back
to the undifferentiated state (Jaenisch and Young, 2008). In
somatic cell nuclear transfer (SCNT), also referred to as thera-
peutic cloning, the nucleolus of a somatic cell is transferred to
the cytoplasm of an enucleated egg to create a blastocyst genet-
ically identical to the parental source and to derive pluripotent
ESC-like stem cells (Hochedlinger and Jaenisch, 2006). However,
SCNT still needs the donor oocyte to direct the reprogramming of
the somatic cell, and most cloned animals exhibit severe pheno-
typic and gene expression abnormalities (Humpherys et al., 2002;
Ogonuki et al., 2002; Tamashiro et al., 2002). Therefore, SCNT is
not a feasible option for cell-based transplantation. Although the
mechanism by which transformation occurs and the mediators of
nuclear reprogramming are largely undefined, the search for fac-
tors that are able to induce complete nuclear reprogramming has
provided recent breakthroughs in the development of successful
iPS technologies.
In 2006, Takahashi and Yamanaka reported the successful
derivation of iPS cells from embryonic and adult mouse fibrob-
lasts through the ectopic co-expression of only four genes: Oct4,
Sox2, Klf4, and c-Myc (Takahashi and Yamanaka, 2006). The
expression of these genes was sufficient to reprogram somatic cells
to an ESC-like pluripotent state. Tissues from different species
such as mice (Takahashi and Yamanaka, 2006), rats (Liao et al.,
2009), rhesus monkeys (Liu et al., 2008), and humans (Takahashi
et al., 2007) have been used as source materials for iPS cell line
generation. Successful reprogramming also quickly translated to
a wide variety of other cell types, including pancreatic β-cells
(Stadtfeld et al., 2008), neural stem cells (Eminli et al., 2008)
mature B cells (Hanna et al., 2008), stomach and liver cells (Aoi
et al., 2008), melanocytes (Utikal et al., 2009), adipose stem cells
(Sun et al., 2009), and keratinocytes (Maherali and Hochedlinger,
2008), demonstrating a universal capacity to alter cellular iden-
tity. In dentistry, iPS cells have been generated from many types
of dental tissues/cells, including SHEDs, SCAPs, DPSCs, tooth
germ progenitor cells (TGPCs), buccal mucosa fibroblasts, gin-
gival fibroblasts, and periodontal ligament fibroblasts (Egusa et
al., 2010; Miyoshi et al., 2010; Oda et al., 2010; Tamaoki et al.,
2010; Yan et al., 2010; Wada et al., 2011). DPSCs show much
higher reprogramming efficiency than the conventionally used
dermal fibroblasts and high expression of endogenous repro-
gramming factors such as c-Myc and KLF4 and/or ESC marker
genes (Tamaoki et al., 2010). Because these cells are easily accessi-
ble by dentist, iPS cells generated from dental tissues are expected
to be a promising cell source for tissue regeneration.
iPS cells have shown pluripotency similar to that of ESCs. They
can produce cells from all three germ layers in vitro and form
teratomas when injected into immunodeficientmice and can con-
tribute to chimera formation (Takahashi and Yamanaka, 2006).
Murine iPS cells also fulfill the strict pluripotency criteria for
contribution to the germline (Okita et al., 2007) and tetraploid
embryo complementation (Woltjen et al., 2009). Moreover, they
can maintain self-renewal when cultured under conditions simi-
lar to those used for ESCs. Hence, iPS cells are often described as
indistinguishable from ESCs. However, the question of whether
iPS cells and ESCs are molecularly and functionally equivalent
is raised by the artificial nature of induced pluripotency. Recent
analyses have shown a high degree of similarity between ESCs and
iPS cells in terms of global gene expression and histone methyla-
tion (Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007;
Mikkelsen et al., 2008). However, substantial differences between
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them have also been reported. In addition, other studies have
indicated that iPS cells retain an epigenetic memory of their for-
mer phenotype that can limit their differentiation potential (Kim
et al., 2010; Polo et al., 2010). Therefore, further study of iPS cells
and ESCs is required to determine whether differences between
them may affect their differentiation potential and their overall
safety and efficiency after transplantation.
There are several advantages of using iPS cells for regener-
ative medicine. Their use can overcome the ethical and politi-
cal issues associated with the use of embryonic cells. They can
be used as autologous and patient-specific cells, which elimi-
nates issues related to the immune rejection of grafts, and can
thus be expected to become the major tool in the advancement
of personalized medicine (Ferreira and Mostajo-Radji, 2013).
Furthermore, iPS cell production can easily be scaled up, which
essentially provides an unlimited source of cells for clinical appli-
cations, in contrast with adult stem cells.
In addition to regenerative medicine, newly emerging appli-
cations of iPS cells are related to in vitro disease modeling and
drug screening (Ebert et al., 2012). Tissue-specific iPS-derived
cells generated from patients with complex genetic defects can be
used to model diseases in studies to elucidate the complex mech-
anisms underlying various diseases and to search for new drugs.
Primary human cells carrying the disease of interest are usually
difficult or impossible to isolate, and even if it is possible to iso-
late them, in most cases, the cells do not proliferate adequately to
produce sufficient numbers of cells for analysis. In contrast, iPS
cells derived from the patient can proliferate abundantly and dif-
ferentiate into cells that represent the pathological character of the
disease. Numerous groups have reported the creation of iPS cells
specific for various diseases, including Parkinson’s disease, amy-
otrophic lateral sclerosis, and familial dysautonomia, in studies to
elucidate the mechanism of their development and progression
and to search for suitable drugs (Dimos et al., 2008; Park et al.,
2008; Lee et al., 2009).
Another therapeutic potential of iPS cells has been demon-
strated in proof-of-principle studies. Hanna et al. (2007) used
a humanized mouse model of sickle cell anemia to determine
the repair potential of progenitor cells derived from autologous
iPS cells. Fibroblasts from the diseased mice were reprogrammed
into an iPS clone and the mutant gene was corrected by homolo-
gous recombination; the pluripotent cells then differentiated into
hematopoietic progenitors and were transplanted back into the
mice. This therapy resulted in substantial improvement of symp-
toms. In another milestone study, healthy iPS-derived dopamin-
ergic neurons were implanted into the brain of a rat model of
Parkinson’s disease. The implanted cells were functionally inte-
grated and the disease condition was improved (Wernig et al.,
2008).
DIFFERENTIATION OF iPS CELLS INTO EPITHELIAL
STEM/PROGENITOR CELLS DURING TERATOMA FORMATION
Teratomas that occur naturally in the ovaries are a useful tool
for studying the development of tissues and organs because they
consist of a variety of tissue elements derived from two or more
embryonic germ layers (Linder et al., 1975). They have been
shown to contain ectodermal appendages, such as teeth and
hair, and are a unique material for investigating the mechanisms
involved in morphogenesis. Therefore, although tumorigenesis
may be a critical issue in the clinical application of iPS cells, these
teratomas should provide an excellent model for investigating
tooth formation and organogenesis and lead to novel bioengi-
neering approaches in regenerative medicine (Gerecht-Nir et al.,
2004; Nussbaum et al., 2007). We therefore examined the pro-
cesses of epithelial histogenesis and the properties of epithelial
tissues and whether or not epithelial stem/progenitor cells, which
have the capacity to induce tooth organogenesis, were found in
iPS-derived teratomas (Kishigami et al., 2012). After mouse iPS
cells were transplanted subcutaneously, iPS cell-derived teratomas
(days 7, 14, and 21) were evaluated histologically. In terms of the
histomorphological features of the epithelium, compact epithelial
mass structures composed of non-polarized cells were dominant
during early teratoma growth (day 7), whereas mature struc-
tures, such as pseudostratified ciliated epithelium and keratinized
stratified squamous epithelium, increased as the teratomas devel-
oped (days 14–21) (Kishigami et al., 2012). Furthermore, other
mature tissues, such as bone and cartilage, became evident in late
teratomas (day 21) (Kishigami et al., 2012). These results sug-
gest that the processes observed during epithelial histogenesis in
iPS cell-derived teratomas may mimic those occurring in normal
embryonic development and provide a useful model for studying
the formation of tissue structures during early development.
To study the presence of epithelial stem/progenitor cells in iPS
cell-derived teratomas, immunohistochemical analysis was per-
formed using antibodies for the epithelial stem/progenitor cell
markers p63 and CD49f and dental epithelial cell marker keratin
14 (K14) (Salmivirta et al., 1996; Pellegrini et al., 2001; Kawano
et al., 2004; Laurikkala et al., 2006). K14 and p63 were detected
in epithelial masses, basal layer of stratified epithelium, and pseu-
dostratified epithelium. CD49f was detectable in all epithelium
types from day 7; in particular, it was strongly expressed in epithe-
lial masses and basal layer of stratified epithelium (Kishigami et
al., 2012). These results provide important insights into the devel-
opment of epithelial tissues during spontaneous differentiation of
iPS cells in vivo.
However, regardless of the presence of putative epithelial
stem/progenitor cells, iPS cell-derived teratomas that formed in
these conditions did not contain teeth, and no tooth germ-like
structures could be found (n = 10, unpublished data). This sug-
gests that a specific signaling network for tooth organogenesis is
missing.
APPROACHES TO TOOTH REGENERATION USING iPS CELLS
Because of recent advances in tissue engineering technology,
functional teeth can be formed from dissociated tooth germ cells.
Several groups have demonstrated that it is possible to produce
biological teeth similar in appearance to natural teeth on the basis
of tissue–cell or cell–cell recombination using embryonic tooth
germ cells (Hu et al., 2005, 2006a; Nakao et al., 2007; Honda et
al., 2008; Nait Lechguer et al., 2008, 2011). In addition, using
tissue/cell recombination techniques, non-dental stem cells such
as ESCs, neural stem cells, and bone marrow-derived cells have
been shown to respond to inductive signals from embryonic den-
tal epithelium (Ohazama et al., 2004). Depending on the stage,
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dental epithelium or mesenchyme from the tooth germ has an
inductive potential for differentiating even non-dental stem cells
into odontogenic cells.
To investigate whether dental mesenchymal cells in the tooth
germ could induce undifferentiated mouse iPS cells to form
dental epithelial cells, DsRed-expressing iPS cells were com-
bined with E14.5 dental mesenchyme and transplanted together
with collagen sponges under the kidney capsule in immun-
odeficient mice. Four weeks after transplantation, tooth germ-
like structures in iPS cell-derived teratomas were observed,
and iPS cells expressed an ameloblast marker, amelogenin,
indicating that iPS cells had differentiated into ameloblasts
(Figure 1). However, the results of these transplantation exper-
iments had poor reproducibility (<10%) and the numbers
of tooth germ-like structures in the teratomas were very
small (<2 per teratoma). Therefore, it appeared that more
specific and suitable exogenous signals would be necessary
to induce undifferentiated iPS cells to acquire odontogenic
characteristics.
Tooth development is controlled by reciprocal interactions
between dental mesenchymal cells derived from NC and den-
tal epithelial cells derived from ectodermal epithelium (Thesleff
and Sharpe, 1997; Jernvall and Thesleff, 2000). Epithelial–
mesenchymal interactions also control the terminal differentia-
tion of odontoblasts and ameloblasts (Ruch et al., 1995; Imai et
al., 1996). Thus, as a new strategy for tooth regeneration, we spec-
ulated that ectodermal epithelial cells and NC cells induced from
iPS cells could be the optimal cell source for the regeneration of
whole teeth (Figure 2).
A protocol for differentiation to NC (Figure 3), originally
developed for human ES cells (Lee et al., 2007; Bajpai et al.,
2009), efficiently induced mouse iPS cells to differentiate into
neural crest-like cells (NCLCs) (Otsu et al., 2012b). These
NCLCs expressed several NC cell markers, including AP-2α,
Wnt-1, and p75NTR, and an MSC marker (Stro-1). Pax3, Snail,
and Slug (NC-specific transcription factors), as well as human
natural killer-1 (HNK-1, also known as CD57 and LEU7; a
marker for migrating NC cells) showed higher expression in
derived cells than in undifferentiated iPS cells (Otsu et al.,
2012b).
Importantly, NCLCs did not form teratomas when they were
injected subcutaneously together with collagen gel into immun-
odeficient mice, possibly because of the disappearance of Nanog,
which is a marker of undifferentiated iPS cells (Okita et al., 2007)
and subtly linked to tumorigenesis (Chiou et al., 2008). This result
suggests that NCLCs derived from iPS cells can overcome the crit-
ical problem of tumorigenesis in the clinical application of iPS cell
transplantation in vivo (Ben-David and Benvenisty, 2011).
When NCLCs were cultured in dental epithelial cell-
conditioned medium, the expression of DSPP, a precursor pro-
tein of dentin sialoprotein (DSP), was significantly increased.
Recombinant culture between NCLC and E14.5 dental epithe-
lium in a collagen gel (Otsu et al., 2012a) or an agar-containing
semi-solid medium (Hu et al., 2005; Keller et al., 2011) showed
that NCLCs expressed the odontoblast marker DSP (Otsu et al.,
2012b). Moreover, after transplantation under the kidney capsule
in immunodeficient mice, the recombinant demonstrated calci-
fied tooth germ-like structures with bone (Figure 4), indicating
that iPS cell-derived NCLCs have the capacity to differentiate
into odontoblasts via their reciprocal interaction with dental
epithelium.
In addition to our recent results, several reports have demon-
strated the potential of iPS cells for odontogenic differentiation.
The hanging dropmethod on a collagen type-I scaffold combined
with BMP-4 induced mouse iPS cells to form odontoblast-like
cells without epithelial–mesenchymal interaction (Ozeki et al.,
2013). These authors further demonstrated that integrin α2 in iPS
cells mediated their differentiation into odontoblasts. BMP-4 was
also shown to induce iPS cells to form both ameloblast-like and
odontoblast-like cells when used with ameloblast serum-free con-
ditioned medium (Liu et al., 2013). Moreover, co-culture with an
ameloblastin-expressing dental epithelial cell line led to efficient
induction of iPS cells into ameloblasts via neurotrophic factor
NT-4 and BMP-4 signaling (Arakaki et al., 2012). These results
strongly suggest that BMP-4 is a key molecule for odontogenic
differentiation from iPS cells.
The ability of iPS cells to form tooth-like structures in vivo
has also been confirmed by using recombination with tooth germ
cells following transplantation under the kidney capsule (Wen
et al., 2012; Cai et al., 2013). Furthermore, combination of iPS
FIGURE 1 | Odontogenic response of undifferentiated iPS cells.
DsRed-expressing iPS cells were subcutaneously transplanted
together with E14.5 mouse first molar mesenchyme cells. (A) H-E
staining showing tooth like structures formed in iPS cell-derived
teratoma. Bar = 100μm. (B) Immunostaining for DsRed in the
area shown by a rectangle in (A). Bar = 10μm. (C)
Immunostaining for amelogenin in the serial section shown in (B).
Bar = 10μm.
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FIGURE 2 | General schematic representation of the current strategy for
whole tooth regeneration using iPS cells. The patient’s somatic cells are
harvested. Reprogramming conditions/factors are introduced to induce
self-renewal and pluripotency, and patient-specific iPS cells are established.
iPS cells are induced to form ectodermal epithelial cells and neural
crest-derived mesenchymal cells, and they are further induced to form
odontogenic cells in vitro. The two cell populations are combined by direct
contact, mimicking the in vivo arrangement. Interaction of these cells leads to
formation of an early-stage tooth germ. Once transplanted into the mouth,
the recombinants develop and lead to functional recovery from tooth loss.
FIGURE 3 | Protocol for induction of iPS cells into NC cells. iPS cells were
differentiated in suspension to form neural spheres. The spheres
spontaneously attached and formed rosette-like structures. The cells
migrated away from the rosette. The migratory cells formed a uniform
population of NCLCs. These images are reproduced with permission from a
study reported in Stem Cells and Development (Otsu et al., 2012b).
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FIGURE 4 | Odontogenic response of NCLCs derived from iPS cells
to dental epithelium. (A) Image showing appearance of the
recombinant between NCLCs and dental epithelium 2 weeks after
transplantation under the kidney capsule. Bar = 500μm. (B)
Histological section of the recombinant showing tooth-like structure.
Bar = 200μm. Cells inside the dentin-like structure were positive for
odontoblast markers DSP (C, Bar = 10μm) and nestin (D, Bar =
25μm).
cells with enamel matrix derivatives was shown to greatly enhance
periodontal tissue regeneration by promoting the formation of
cementum, alveolar bone, and periodontal ligaments (Duan et
al., 2011), indicating the possibility of iPS cell-based periodontal
tissue regeneration.
CONCLUDING REMARKS
In this review, we discuss the potential of stem cell-based tooth
regeneration, including the use of iPS cells. This field of research
provides an attractive alternative to traditional and current prac-
tices for the replacement of missing teeth, such as implants
and classic procedures based on synthetic materials. Because of
rapidly increasing research efforts and progress, it is anticipated
that clinically satisfactory functional tooth regeneration will be
available in the near future. In particular, as part of a new technol-
ogy, patient-specific iPS cells are a highly promising cell source for
personalized regenerative dental medicine because of their poten-
tial to overcome the shortcomings of adult (tissue) stem cells and
embryonic cells. The future establishment of this technique may
considerably change therapeutic approaches to dental syndromes
and diseases.
However, some challenges remain to be addressed before suc-
cessful tooth regeneration can be achieved. For example, natural
tooth development generally takes several years to complete in
humans, which is too long to wait for a patient who needs regen-
erated teeth. Therefore, we should address this issue carefully
when considering clinical applications. In addition, because mor-
phology and size differ depending on the tooth type, these aspects
need to be addressed. We also need to further develop efficient
protocols to induce stem cells to form cell types in vitro that are
relevant to the tissues and organs targeted for regeneration. To
succeed in these challenges, further basic studies to elucidate the
regulatory mechanisms of stem cells and tooth development are
needed.
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